Matt Hernan
San Francisco Bay Area
323 followers
310 connections
323 followers
310 connections
View mutual connections with Matt
Matt can introduce you to 10+ people at RAPT Therapeutics
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Matt
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Articles by Matt
-
What does Moderna Therapeutics do, and why is it a Silicon Valley secret?
What does Moderna Therapeutics do, and why is it a Silicon Valley secret?
Surprising, yet not surprising. VC and Wall Street greed.
2
Activity
323 followers
No more previous content
-
Matt Hernan liked thisMatt Hernan liked thisHonored to see our science lit up on the NYSE trading floor today, congratulating our team on the recent Nature Portfolio publication featuring ARC-20 trial data. Grateful for the recognition 🔬🎊 Learn more about the research here: https://bit.ly/4gS5jzv
-
Matt Hernan liked thisMatt Hernan liked thisAt #EULAR2026, we presented two posters advancing our research in immunology and inflammation, both exploring new approaches for conditions such as #RheumatoidArthritis and #InflammatoryBowelDisease: ✔️ A small-molecule approach to TNF inhibition, designed to block pro-inflammatory TNF signaling while preserving the beneficial signaling that anti-TNF biologics block. ✔️ New findings on CD89, an immune receptor involved in neutrophil-driven inflammation, and the IgA-CD89-neutrophil axis as a potential therapeutic target. Learn more about this research: https://bit.ly/4e9pS7P +++ “Our TNF small molecule inhibitor targets pro-inflammatory TNFR1 signaling while sparing anti-inflammatory TNFR2 signaling. CD89 inhibition selectively targets neutrophils, offering potential benefit to patients whose disease isn't adequately controlled by standard-of-care therapies.” -Matthew Walters, Ph.D. Senior Vice President, Biology Arcus Biosciences
-
Matt Hernan liked thisOne thing I’ve been noticing more lately: AI companies aren’t just competing with biotech for talent anymore, they’re increasingly competing for the same technical space as well. That creates a really interesting dynamic in the Bay Area, especially as former office and lab environments continue to get repurposed depending on the cycle. What stands out to me is how similar some of the operational requirements are becoming: • power • cooling • infrastructure flexibility • speed to occupancy Feels like we’re watching another evolution of what “technical space” in the Bay Area actually means. Curious if others are seeing the same crossover. #PraxisOps #Biotech #AI #LifeSciences #Facilities #LabOperations #RealEstateMatt Hernan liked this🧠 𝗔𝗜 𝗜𝘀𝗻’𝘁 𝗝𝘂𝘀𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝗧𝗮𝗹𝗲𝗻𝘁 — 𝗜𝘁’𝘀 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝗟𝗮𝗯 𝗦𝗽𝗮𝗰𝗲 One of the more interesting shifts in the Bay Area right now: AI and advanced technology companies are increasingly competing for the same technical real estate that biotech companies have relied on for years. According to recent market data: ⚡ More than 𝟰𝟬𝟬,𝟬𝟬𝟬 𝗦𝗙 has recently been absorbed by advanced manufacturing and AI users ⚡ OpenAI alone removed approximately 𝟮𝟴𝟬,𝟬𝟬𝟬 𝗦𝗙 from San Francisco availability That’s a meaningful shift. For years, many traditional office buildings were converted into biotech lab space. Now we’re starting to see part of that cycle reverse: 🔹 AI users taking over former lab environments 🔹 Technical infrastructure being repurposed 🔹 Demand increasing for power-heavy buildings and flexible R&D space What makes this interesting is that the competition isn’t just about rent. It’s about: ⚡ power capacity ⚡ cooling ⚡ infrastructure ⚡ speed to occupancy ⚡ adaptability of the building itself In many cases, biotech and AI companies are now evaluating the same operational characteristics, just for different forms of innovation. From an operator’s perspective, this creates a new layer of complexity: 👉 higher competition for technical space 👉 more pressure on infrastructure 👉 and potentially fewer flexible options over time The Bay Area has always followed cycles of capital and innovation. What’s changing now is how quickly those cycles are reshaping the built environment around them. 👉 Curious if others are seeing more overlap between biotech and AI space demand. #PraxisOps #Biotech #AI #LifeSciences #LabSpace #Facilities #RealEstate #BayAreaBiotech #Innovation #LabOperations
-
Matt Hernan liked thisMatt Hernan liked thisSunshine, good food, and even better company. Arcus’s spring BBQ is always a reminder that behind the science is a community that genuinely shows up – for the joy of the work and for each other. Here's to Team Arcus!
-
Matt Hernan liked thisMatt Hernan liked thisWelcome to the latest edition of THE NEWS, Pacific Science Quarterly Newsletter, where we share key updates, insights, and resources. As a trusted provider of cold storage solutions, we’re excited to bring the newest developments from across our team and the industry. 👉 Read the full April 2026 newsletter here. https://lnkd.in/dav7jyFu Learn more about Pacific Science, LLC cold storage products and services, https://lnkd.in/gSPygSaQ #coldstorage #labequipment #pacificscience #newsletter
-
Matt Hernan liked thisSo exciting to head to Philadelphia this week with my amazing backpacking trip co-leaders to wrap up the filming for our documentary featuring early career women scientists from Penn learning leadership skills through wilderness adventure.Matt Hernan liked this🇺🇸 I feel deeply impressed and inspired: This was our week in Philadelphia ⬇️ Yannik and I spent the past days in Philadelphia to wrap up an exciting project: 📝 We had the opportunity to speak with Drs. Kristen Hege, Kathleen Abadie, Florence (Chardon) Abadie, Carl June and Bruce Levine about the topic of Women in Science, and especially in leadership positions. Thank you, University of Pennsylvania for helping to make this possible. Honestly, it was a truly inspiring week with meaningful conversations. Also, a big thank you to our U.S. production partners Sara Sampey and Austin Lysaker for the great collaboration. 🎥 We’re looking forward to the final result and are very proud to tell here an inspiring story. Stay tuned for more. 🍿🎬 Looking forward to seeing you again! Francesca Costabile Sisi Chen Sara Sleiman Amanda Finck Shawna Brookens, PhD Fiona O'Connell, PhD Kisha Patel Production: Tell Us GmbH #tellus #WeeklyRecap #FilmProduction #StoryDriven #WomenInScience #Leadership #Documentary #USproduction #RealStories
-
Matt Hernan liked thisThrilled to have joined my co-chairs in putting together a spectacular Society for Immunotherapy of Cancer (SITC) spring scientific summit. I am especially proud of the diversity we had in our speakers: women, men, academia, biotech and pharma presenting on the most exciting advances in IO. Together we are advancing science and medicine in truly spectacular ways.Matt Hernan liked thisToday is the closing day of the #SITC 2026 Spring Scientific - Next-generation Cellular Therapies, T cell Engagers, and Combinations. It has been an incredible week. Amazing science, intriguing presentations, powerful keynote address and relationship building through opportunities for networking. SITC would like to thank all of the attendees, abstract presenters, moderators and valued faculty. None of this would be possible with out the support of the exhibitors and supporters. And last, but definitely not least, a BIG shout out to our dedicated organizers whose vision made this event come to fruition! Organizers: Kristen Hege, MD – Board Member: Mersana, Adaptimmune, Kelonia, KSQ and EvolveImmune Ashley Koegel, MD – Bristol Myers Squibb Gordon Moody, MS – AstraZeneca Daniel Powell, Jr., PhD – University of Pennsylvania Evan Weber, PhD – University of Pennsylvania Learn more about this event here (you can still register to receive access to the enduring materials): https://lnkd.in/gw_kXHji #SITCQuestfor100 #TCE #Immunotherapy #SITC26 #Gratitude
-
Matt Hernan liked thisMatt Hernan liked thisHow do you celebrate 22 years of success? With a transformative culture, a bright future, and... Monday Tacos. 🌮🎉 A massive shoutout and congratulations to our founders, Andy Pashby & Paul Pashby. Thank you for building a transformative environment where every employee has the space to truly thrive. LBI has remained a constant force regardless of what market trends have to say. The future is looking incredibly bright, and we’re ready to take on whatever comes next. O ya, Matthew Caywood, thanks for cheffing up a great meal! #dontgetlastinfantasyfootball
No more next content
Experience
View Matt’s full profile
-
See who you know in common
-
Get introduced
-
Contact Matt directly
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content